查詢結果分析
來源資料
頁籤選單縮合
題 名 | 治療癌因性疲憊之新藥介紹--黃耆多醣=Introduction of New Drugs for Cancer-Related Fatigue--Astragalus Polysaccharides |
---|---|
作 者 | 鄭曉倩; | 書刊名 | 腫瘤護理雜誌 |
卷 期 | 13:2 2013.12[民102.12] |
頁 次 | 頁33-37 |
分類號 | 414.5 |
關鍵詞 | 癌症; 癌因性疲憊; 黃耆多醣; Cancer; Cancer-related fatigue; Astragalus polysaccharides; |
語 文 | 中文(Chinese) |
中文摘要 | 癌因性疲憊(cancer-related fatigue,CRF)是癌症治療範疇中,極易被忽略的症狀,屬國際疾病分類ICD-10-CM明確定義的疾病。美國國家癌症資訊網(National Comprehensive Cancer Network,NCCN)所提出癌因性疲憊指引中說明,改善「癌因性疲憊」的方式有非藥物治療與藥物治療兩大類,在藥物治療方面,目前臺灣衛生福利部食品藥物管理署核准的「黃耆多醣注射劑」是一種由醫藥中補氣益虛之上藥黃耆(Astragalus Membranaceus),經由萃取分離以及純化而成之黃耆多醣(Astragalus Polysaccharides),具雙向免疫調節作用,同時能增強使用者的免疫力,尤其以疲勞症狀的改善效果最為顯著,能有效改善癌症病患的生活品質。 |
英文摘要 | Cancer-related fatigue (CRF) is commonly experienced by cancer patients. However CRF is often disregarded by healthcare professionals. The International Classification of Diseases (ICD-10-CM) has clearly defined the disease in 1998. The National Comprehensive Cancer Network (NCCN) had set up the guidelines for the management of cancer-related fatigue, including non-pharmacological and pharmacological interventions. The injection of astragalus polysaccharides approved by Taiwan Food and Drug Administration, is a specific fraction of polysaccharides isolated from the radix of astragalus membranaceus, a commonly used herbal component in traditional Chinese medicine. Astragalus polysaccharides injection is a bidirectional immunomodulatory agent that can enhance the patient's immune function, most of all, it can improve cancer-related fatigue and maintain the patients' quality of life in a better condition. |
本系統中英文摘要資訊取自各篇刊載內容。